CORDIS
EU research results

CORDIS

English EN
Effects of Prenatal Exposure to Acrylamide on Health: Prospective Biomarker-Based Studies

Effects of Prenatal Exposure to Acrylamide on Health: Prospective Biomarker-Based Studies

Objective

Background: Acrylamide is a chemical formed in many commonly consumed foods and beverages. It is neurotoxic, crosses the placenta and has been associated with restriction of fetal growth in humans. In animals, acrylamide causes heritable mutations, tumors, developmental toxicity, reduced fertility and impaired growth. Therefore, the discovery of acrylamide in food in 2002 raised concern about human health effects worldwide. Still, epidemiological studies are limited and effects on health of prenatal exposure have never been evaluated.

Research gaps: Epidemiological studies have mostly addressed exposure during adulthood, focused on cancer risk in adults, and relied on questionnaires entailing a high degree of exposure misclassification. Biomarker studies on prenatal exposure to acrylamide from diet are critically needed to improve exposure assessment and to determine whether acrylamide leads to major diseases later in life.

Own results: I have first authored a prospective European study showing that prenatal exposure to acrylamide, estimated by measuring hemoglobin adducts in cord blood, was associated with fetal growth restriction, for the first time.
Objectives: To determine the effects of prenatal exposure to acrylamide alone and in combination with other potentially toxic adduct-forming exposures on the health of children and young adults.

Methods: Both well-established and innovative biomarker methods will be used for characterization of prenatal exposure to acrylamide and related toxicants in blood from pregnant women and their offspring in prospective cohort studies with long-term follow-up. Risk of neurological disorders, impaired cognition, disturbed reproductive function and metabolic outcomes such as obesity and diabetes will be evaluated.
Perspectives: CHIPS project will provide a better understanding of the impact of prenatal exposure to acrylamide from diet on human health urgently needed for targeted strategies for the protection of the health.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Host institution

KOBENHAVNS UNIVERSITET

Address

Norregade 10
1165 Kobenhavn

Denmark

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 113 525,42

Beneficiaries (2)

Sort alphabetically

Sort by EU Contribution

Expand all

KOBENHAVNS UNIVERSITET

Denmark

EU Contribution

€ 1 113 525,42

STOCKHOLMS UNIVERSITET

Sweden

EU Contribution

€ 386 005,58

Project information

Grant agreement ID: 758151

Status

Ongoing project

  • Start date

    1 July 2018

  • End date

    30 June 2023

Funded under:

H2020-EU.1.1.

  • Overall budget:

    € 1 499 531

  • EU contribution

    € 1 499 531

Hosted by:

KOBENHAVNS UNIVERSITET

Denmark